CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer

PURPOSE: The present study is to investigate the significance of CD44 variant 9 (CD44v9) expression as a biomarker in primary gastric cancer. MATERIALS AND METHODS: With various gastric tissues, we performed immunohistochemical staining for CD44v9. RESULTS: The positive expression rates for CD44v9 i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res Treat
Main Authors: Go, Se-Il, Ko, Gyung Hyuck, Lee, Won Sup, Kim, Rock Bum, Lee, Jeong-Hee, Jeong, Sang-Ho, Lee, Young-Joon, Hong, Soon Chan, Ha, Woo Song
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720095/
https://ncbi.nlm.nih.gov/pubmed/25779358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.227
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados